Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
暂无分享,去创建一个
[1] Edward Blair,et al. “Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project , 2017, Genetics in Medicine.
[2] Susan Kelly,et al. A 'joint venture' model of recontacting in clinical genomics: challenges for responsible implementation. , 2017, European journal of medical genetics.
[3] J. Knight,et al. Insights from early experience of a Rare Disease Genomic Medicine Multidisciplinary Team: a qualitative study , 2017, European Journal of Human Genetics.
[4] Debra J. H. Mathews,et al. Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease , 2017, European Journal of Human Genetics.
[5] A. Clarke,et al. Recontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom , 2017, European Journal of Human Genetics.
[6] M. Szego,et al. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm? , 2016, Journal of Medical Ethics.
[7] W. Chung,et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.
[8] Michael Parker,et al. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies , 2016, Genetics in Medicine.
[9] J. Ivanovich,et al. Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age , 2016, Clinical genetics.
[10] L. Garraway,et al. Oncologists' and Cancer Patients' Views on Whole-Exome Sequencing and Incidental Findings: Results from The CanSeq Study , 2016, Genetics in Medicine.
[11] S. Bowdin,et al. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine , 2016, Clinical genetics.
[12] B. Knoppers,et al. Stability of Attitudes to the Ethical Issues Raised by the Return of Incidental Genomic Research Findings in Children: A Follow-Up Study , 2015, Public Health Genomics.
[13] Davis J. McCarthy,et al. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders , 2015, Nature Genetics.
[14] B. Fernandez,et al. The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists , 2015, Journal of Medical Genetics.
[15] A. Lemke,et al. Stakeholder engagement in policy development: challenges and opportunities for human genomics , 2015, Genetics in Medicine.
[16] Jennifer B. McCormick,et al. Patients' views on incidental findings from clinical exome sequencing , 2015, Applied & translational genomics.
[17] Erwin Birnie,et al. Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature , 2014, Genetics in Medicine.
[18] J. Veltman,et al. Clinical exome sequencing in daily practice: 1,000 patients and beyond , 2014, Genome Medicine.
[19] Amie M. Blanco,et al. Lynch Syndrome Patients’ Views of and Preferences for Return of Results Following Whole Exome Sequencing , 2014, Journal of Genetic Counseling.
[20] J. Vermeesch,et al. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. , 2014, Human reproduction.
[21] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[22] R. Green,et al. How could disclosing incidental information from whole-genome sequencing affect patient behavior? , 2013, Personalized medicine.
[23] Susan M Wolf,et al. Patient Autonomy and Incidental Findings in Clinical Genomics , 2013, Science.
[24] Robert C. Green,et al. Ethics and Genomic Incidental Findings , 2013, Science.
[25] Alexander A. Morgan,et al. Clinical assessment incorporating a personal genome , 2010, The Lancet.
[26] P. Sainsbury,et al. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[27] Muin J Khoury,et al. What is the clinical utility of genetic testing? , 2006, Genetics in Medicine.
[28] V. Braun,et al. Using thematic analysis in psychology , 2006 .
[29] Janet K. Williams,et al. Toward a biopsychosocial model for 21st-century genetics. , 2005, Family process.
[30] Pascal Borry,et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. , 2013, European journal of human genetics : EJHG.